Search Within

Thoracic Oncology

  1. "Division of Subspecialty Medicine "
Formats
  1. Journal Article (55)
  2. Meeting Abstract (26)
  3. Review (3)
  4. Correspondence (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (86)
  2. Division of Subspecialty Medicine (86)
  3. Solid Tumor Oncology Division (86)
  4. Survivorship Research (45)
  5. Dermatology (29)
  6. Dermatology Service (29)

More Groups

People
  1. Mario Lacouture (27)
  2. Matthew Hellmann (22)
  3. Alexander Drilon (21)
  4. Mark Kris (16)
  5. Jamie Chaft (14)
  6. Charles Rudin (11)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (6)
  4. 2022 (12)
  5. 2021 (12)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Journal of Thoracic Oncology (8)
  3. Annals of Oncology (6)
  4. Cancer Immunology Research (3)
  5. JTO Clinical and Research Reports (3)
  6. Supportive Care in Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. Elsevier Inc. (13)
  3. Oxford University Press (9)
  4. Nature Publishing Group (7)
  5. American Association for Cancer Research (5)
  6. Springer (4)

More Publishers

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic toxicities of 3,517 solid tumor patients on phase I clinical trials of the National Institutes of Health Cancer Therapy Evaluation Program (CTEP)
    Meeting Abstract

    Drilon, A. E.; Eaton, A.; Schindler, K.; Gounder, M. M.; Smith, G. L.; Vulih, D.; Harris, P. J.; Spriggs, D. R.; Ivy, P.; Iasonos, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Meeting Abstract

    Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Acupuncture for the treatment of post-chemotherapy chronic fatigue: A randomized, blinded, sham-controlled trial
    Journal Article

    Deng, G.; Chan, Y.; Sjoberg, D.; Vickers, A.; Yeung, K. S.; Kris, M.; Straus, D.; Cassileth, B.
    Supportive Care in Cancer (2013)

    Fulltext@MSK | Save
  • The value of "patient death debriefing sessions" for internal medicine trainees in an oncology setting
    Meeting Abstract

    Jhanwar, S.; Schulman, E.; Eng, J.; Pessin, H.; Shah, M.
    Psycho-Oncology (2013)

    Fulltext@MSK | Save
  • Toxicity of initial chemotherapy in older patients with lung cancers
    Journal Article

    Zauderer, M. G.; Sima, C. S.; Korc-Grodzicki, B.; Kris, M. G.; Krug, L. M.
    Journal of Geriatric Oncology (2013)

    Fulltext@MSK | Save
  • Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas
    Journal Article

    Lito, P.; Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; Wong, W. L.; Callahan, M. K.; Merghoub, T.; more...
    Cancer Cell (2012)

    Fulltext@MSK | Save
  • Can we really treat patients older than age 70 with a chemotherapy doublet for non-small cell lung cancer (NSCLC)?
    Meeting Abstract

    Zauderer, M. G.; Sima, C. S.; Korc-Grodzicki, B.; Kris, M. G.; Krug, L. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Can we predict toxicity in patients over 70 years old treated with chemotherapy for advanced non-small cell lung cancer (NSCLC)?
    Meeting Abstract

    Zauderer, M. G.; Sima, C. S.; Korc-Grodzicki, B.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group
    Journal Article

    Lacouture, M. E.; Maitland, M. L.; Segaert, S.; Setser, A.; Baran, R.; Fox, L. P.; Epstein, J. B.; Barasch, A.; Einhorn, L.; Wagner, L.; more...
    Supportive Care in Cancer (2010)

    Fulltext@MSK | Save
  • Gemcitabine nephrotoxicity and hemolytic uremic syndrome: Report of 29 cases from a single institution
    Journal Article

    Glezerman, I.; Kris, M. G.; Miller, V.; Seshan, S.; Flombaum, C. D.
    Clinical Nephrology (2009)

    Fulltext@MSK | Save